Post Operative
Post Operative
Cara Therapeutics Secures $15 Million Series D Financing to Continue Clinical Development of CR845
SHELTON, Conn., July 21 /PRNewswire/ -- Cara Therapeutics, Inc. announced today that it had closed on a Series D financing of $15 million.  The round was led by new investor, Rho Ventures, with participation from previous investors Alta Biopharma, Ascent Biomedical Ventures, CT Innovations, Devon Park BioVentures, Healthcare Private Equity, Mitsubishi International Corporation and MVM Life Science Partners.

Hospira Announces Successful Completion of Tender Offer for Shares of Javelin Pharmaceuticals
LAKE FOREST, Ill., July 1 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced the successful completion of the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, to purchase all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc.

Bunion Surgery Explained
Fixing a bunion deformity is a common procedure performed thousands of times each day across the country. Unfortunately, many people have misperceptions about the nature of that procedure, how long recovery takes, and the anticipated pain level one would experience in recovery. This article will help answer these questions, and dispel misperceptions about the nature of bunion surgery.


Related News:


Privacy Policy | Copyright/Trademark Notification